Logo

TriLink, Astral Scientific Forge Distribution Deal

Nov 15, 2011

NEW YORK (GenomeWeb News) – TriLink BioTechnologies today announced a distribution deal covering Australia with Astral Scientific for its nucleic acid products.

Products covered by the deal include more than 150 modified nucleotides, custom oligonucleotides, and CleanAmp Hot Start PCR products, San Diego-based TriLink said.

Financial terms of the deal were not disclosed.

Astral supplies core consumables to the clinical diagnostic, life science, and industrial markets.

Filed under

PCR
Molecular Diagnostics
TriLink
Breaking News
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.